US Patent 11358999 IL-12 heterodimeric Fc-fusion proteins
Patent 11358999 was granted and assigned to Xencor on June, 2022 by the United States Patent and Trademark Office.
All edits
Edits on 2 Oct, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 12 Jan, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 27 Dec, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 16 Oct, 2023
Golden AI
Edits made to:
Infobox (+6 properties)
Infobox
Patent Inventor Names
John R. Desjarlais0
Ke Liu0
Matthew Bernett0
Nargess Hassanzadeh-Kiabi0
Rajat Varma0
Rumana Rashid0
Edits on 24 May, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 7 Apr, 2023
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
113589990
Date of Patent
June 14, 2022
0Patent Application Number
165926560
Date Filed
October 3, 2019
0Patent Citations
Patent Primary Examiner
Edits on 25 Mar, 2023
Golden AI
Edits on 16 Jun, 2022
Golden AI
Edits made to:
Infobox (+14 properties)
Article (+222 characters)
US Patent 11358999 IL-12 heterodimeric Fc-fusion proteins
Article
The present invention provides novel IL-12 Fc fusion proteins, methods of making and using the same. The IL-12. Fc fusion proteins are useful for treatment of cancer and can be used in combination with checkpoint blockade.
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
11358999
Date of patent
June 14, 2022
Patent application number
16592656
Date Filed
October 3, 2019
Patent citations
Patent primary examiner
Find more entities like US Patent 11358999 IL-12 heterodimeric Fc-fusion proteins
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
